Treasury Department Proposes Expanding Outbound Investment Screening to Biotechnology
In an effort to protect critical national security capabilities, the U.S. Department of the Treasury has issued a Notice of Proposed Rulemaking to include biotechnology under its outbound investment screening framework. The policy aligns with broader federal initiatives aimed at safeguarding sensitive dual-use technologies from strategic competitors.
Strengthening National Technology Safeguards
The proposed regulations build upon existing restrictions targeting semiconductors, quantum computing, and artificial intelligence. By incorporating advanced biotechnology into federal review protocols, the administration seeks to monitor and regulate domestic private investments flowing into foreign entities that could advance military or intelligence applications abroad.
Industry stakeholders and legal experts are reviewing the compliance implications, noting that the regulations will require heightened due diligence for venture capital and private equity firms operating in life sciences sectors.
FAQ
Q: What new technology sector is being added to investment screening lists?
A: Biotechnology is being incorporated alongside semiconductors, AI, and quantum technology.
Q: Which federal agency is overseeing the proposed rulemaking?
A: The U.S. Department of the Treasury.